#AACR21 📢#ICYMI in @CIR_AACR: When it comes to NK cells (and many other immune cell types 😋😉), CIR has your back! Check out this handful of papers on modulating #NKcell antitumor responses 👇👇 https://t.co/mWnix8iV06 https://t.co/XddMWX5Z5K https://t.co/du
How’s your day going, #AACR21❓ If you are listening in on ‘Therapeutic Mechanisms of Novel Anticancer Agents,’ you may be interested in these topic-related @CIR_AACR papers! #CancerImmunology https://t.co/jBUeUxJFo1 https://t.co/nmFqfWVZc3 https://t.co/du
Read about a next-generation #NKcell #trispecific engager that promotes #IL15 delivery and #AML killing. This could provide off-the-shelf treatment to mobilize NK cells for targeted #Immunotherapy. This earned a #CIRReviewerStar ⭐ #AACRtii20 https://t.co/